Chemomab Therapeutics Ltd.

CMMB ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Jul 25, 2024 6-K
6-K Jun 12, 2024 6-K
6-K May 9, 2024 6-K
6-K May 8, 2024 6-K
6-K May 3, 2024 6-K
20-F Mar 28, 2024 20-F
SC 13D/A Mar 11, 2024 AMENDMENT NO. 3
6-K Mar 7, 2024 6-K
6-K Jan 3, 2024 6-K
SC 13D/A Nov 15, 2023 AMENDMENT NO. 2
6-K Nov 9, 2023 6-K
EFFECT Nov 3, 2023
CORRESP Nov 1, 2023
F-3/A Oct 30, 2023 F-3/A
F-3 Oct 16, 2023 F-3
6-K Aug 14, 2023 6-K
6-K Aug 8, 2023 6-K
4 Jul 5, 2023
6-K Jul 3, 2023 6-K
4 Jun 20, 2023
4 Jun 16, 2023
8-K Jun 16, 2023 8-K
3 Jun 5, 2023
8-K Jun 5, 2023 8-K
RW Jun 2, 2023 RW
← Newer Page 4 of 15 · 369 filings Older →